Short and Long-term Responses of PD Symptoms to Earstim
NCT: NCT07400731 · RECRUITING
Brief Summary
This is a prospective, multicenter, randomized, two-period study designed to evaluate the safety and effectiveness of the EarStim System for intermittent relief of motor symptoms in patients with Parkinson's disease experiencing wearing-off phenomena. Adult patients with moderate to severe Parkinson's disease (MDS-UPDRS Part III score ≥33) receiving oral dopaminergic therapy will be enrolled. Period A is a randomized, double-blind, sham-controlled phase conducted in a clinical setting. Period B is an unblinded, standard-of-care-controlled phase evaluating the effectiveness of the EarStim System during home use over 90 days.
Frequently Asked Questions
What is Short and Long-term Responses of PD Symptoms to Earstim?
Short and Long-term Responses of PD Symptoms to Earstim is a clinical trial registered under NCT07400731. Current status: RECRUITING.
What is the status of NCT07400731?
The current status of NCT07400731 (Short and Long-term Responses of PD Symptoms to Earstim) is: RECRUITING.
When did Short and Long-term Responses of PD Symptoms to Earstim start?
Short and Long-term Responses of PD Symptoms to Earstim started on 2026-03-12.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.